Send me a link:

*Text messaging rates may apply.

 Dow Up 0.04% Nasdaq Up 0.21%

Advaxis, Inc. (ADXS)

-NasdaqCM
2.91 Up 0.05(1.75%) 11:19AM EDT - Nasdaq Real Time Price
Prev Close:2.86
Open:2.96
Bid:2.91 x 1500
Ask:2.94 x 2000
1y Target Est:13.50
Beta:1.11
Next Earnings Date:N/A
Day's Range:2.90 - 2.99
52wk Range:2.46 - 11.70
Volume:41,555
Avg Vol (3m):172,678
Market Cap:56.09M
P/E (ttm):N/A
EPS (ttm):-2.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXSUp 1.75%56.09M
BVTI 0.00%N/A
DNDNUp 0.53%325.89M
VICLUp 1.97%112.45M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):55.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-14) :-1.16
Quarterly EPS Est (Jul-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback